GAMASTANS/D (GRIFOLS USA, LLC)
Welcome to the PulseAid listing for the GAMASTAN drug offered from GRIFOLS USA, LLC. This Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] pharmaceutical is classified as a PLASMA DERIVATIVE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same PLASMA DERIVATIVE drug type category.
LABELER NAME / MANUFACTURER: | GRIFOLS USA, LLC |
NON-PROPRIETARY NAME: | IMMUNE GLOBULIN (HUMAN) |
SUBSTANCE NAME: | HUMAN IMMUNOGLOBULIN G |
TYPE: | PLASMA DERIVATIVE |
PHARMA CLASS: | Human Immunoglobulin G [EPC],Passively Acquired Immunity [PE],Antigen Neutralization [MoA],Immunoglobulins [Chemical/Ingredient] |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 1996-08-14 |
END MARKETING DATE: | 0000-00-00 |
GAMASTAN S/D PLASMA DERIVATIVE Details:
Item Description | GAMASTAN S/D from GRIFOLS USA, LLC |
LABELER NAME: | GRIFOLS USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.165(g/mL) |
START MARKETING DATE: | 1996-08-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 13533-635_d731fee9-8f46-454d-8c10-2b5560e3a304 |
PRODUCT NDC: | 13533-635 |
APPLICATION NUMBER: | BLA101134 |
Other HUMAN IMMUNOGLOBULIN G Pharmaceutical Manufacturers / Labelers: